Cover Image
Market Research Report

Global Oncology Companion Diagnostic Market Size study, by Product & Service, by Technology, by Disease Type, by End User and Regional Forecasts 2020-2027

Published by Bizwit Research & Consulting LLP Product code 962967
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Global Oncology Companion Diagnostic Market Size study, by Product & Service, by Technology, by Disease Type, by End User and Regional Forecasts 2020-2027
Published: October 1, 2020 Content info:
Description

Title:
Global Oncology Companion Diagnostic Market Size study, by Product & Service (Product and Services), by Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) and Others), by Disease Type (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Prostate Cancer and Others), by End User (Hospital, Pathology/Diagnostic Laboratory and Academic Medical Center) and Regional Forecasts 2020-2027.

Global Oncology Companion Diagnostic Market is valued approximately at USD 2.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.7% over the forecast period 2020-2027. Oncology companion diagnostic is an in vitro medical device that provides information for the use of multiple drug or biological oncology products. This diagnostic test helps a health care professional to analyze and determine, whether an oncology or particular therapeutic product is valuable to patients and can outweigh any potential serious side effects or risks. The rising awareness for the advantages of companion diagnostics, growing need for targeted therapy, increasing global incidence of cancer and growing application areas of companion diagnostics are the few factors responsible for growth of the market over the forecast period. As per the Our World in Data Organization, breast cancer is the most prevalent form of cancer with an estimated number of about 17 million people with breast cancer in 2017. Further, as per the source, in 2018, about 2 million new cases were registered breast cancer worldwide. As per the American cancer society, breast cancer is the second leading cause of cancer-related deaths in women across the globe.

Also, according to the World Health Organization (WHO), the total new cases of liver cancer were reported 841,080 in 2018 and an estimated 781, 631 people died due to liver cancer, globally. Further increasing R&D expenditure in pharmaceutical industry for the introduction of better and beneficial drugs for patients will drive the market growth. For instance: as per Statista, the global research and development spending in pharmaceutical industry was USD 186 billion in 2019 and had experienced totaled USD 136 billion in 2012. Also, it is expected to rise by USD 233 billion spending of global research and development in pharmaceutical industry in 2026. However, high cost of companion diagnostic tests and uncertain reimbursement scenario in different regions are the major factors restraining the growth of global Oncology Companion Diagnostic market during the forecast period.

The regional analysis of global Oncology Companion Diagnostic market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the leading/significant region across the world owing to the high incidence of cancer, increasing proteomics & genomics research, growing research funding, rising investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics in several APAC countries.

Major market player included in this report are:

Agilent Technologies, Inc.

Illumina, Inc.

QIAGEN N.V.

Thermo Fisher Scientific, Inc.

F. Hoffmann-La Roche Ltd.

ARUP Laboratories

Abbott

Myriad Genetics, Inc.

bioMerieux SA

Invivoscribe, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Service:

Product

Services

By Technology:

Polymerase Chain Reaction (PCR)

Next-Generation Sequencing (NGS)

Immunohistochemistry (IHC)

In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)

Others

By Disease Type:

Breast Cancer

Non-Small Cell Lung Cancer

Colorectal Cancer

Leukemia

Melanoma

Prostate Cancer

Others

By End Use:

Hospital

Pathology/Diagnostic Laboratory

Academic Medical Center

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Oncology Companion Diagnostic Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Oncology Companion Diagnostic Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Oncology Companion Diagnostic Market, by Product & Service, 2018-2027 (USD Billion)
    • 1.2.3. Oncology Companion Diagnostic Market, by Technology, 2018-2027 (USD Billion)
    • 1.2.4. Oncology Companion Diagnostic Market, by Disease Type, 2018-2027 (USD Billion)
    • 1.2.5. Oncology Companion Diagnostic Market, by End Use, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Oncology Companion Diagnostic Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Oncology Companion Diagnostic Market Dynamics

  • 3.1. Oncology Companion Diagnostic Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Oncology Companion Diagnostic Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Oncology Companion Diagnostic Market, by Product & Service

  • 5.1. Market Snapshot
  • 5.2. Global Oncology Companion Diagnostic Market by Product & Service, Performance - Potential Analysis
  • 5.3. Global Oncology Companion Diagnostic Market Estimates & Forecasts by Product & Service 2017-2027 (USD Billion)
  • 5.4. Oncology Companion Diagnostic Market, Sub Segment Analysis
    • 5.4.1. Product
    • 5.4.2. Services

Chapter 6. Global Oncology Companion Diagnostic Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Oncology Companion Diagnostic Market by Technology, Performance - Potential Analysis
  • 6.3. Global Oncology Companion Diagnostic Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
  • 6.4. Oncology Companion Diagnostic Market, Sub Segment Analysis
    • 6.4.1. Polymerase Chain Reaction (PCR)
    • 6.4.2. Next-Generation Sequencing (NGS)
    • 6.4.3. Immunohistochemistry (IHC)
    • 6.4.4. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
    • 6.4.5. Others

Chapter 7. Global Oncology Companion Diagnostic Market, by Disease Type

  • 7.1. Market Snapshot
  • 7.2. Global Oncology Companion Diagnostic Market by Disease Type, Performance - Potential Analysis
  • 7.3. Global Oncology Companion Diagnostic Market Estimates & Forecasts by Disease Type 2017-2027 (USD Billion)
  • 7.4. Oncology Companion Diagnostic Market, Sub Segment Analysis
    • 7.4.1. Breast Cancer
    • 7.4.2. Non-Small Cell Lung Cancer
    • 7.4.3. Colorectal Cancer
    • 7.4.4. Leukemia
    • 7.4.5. Melanoma
    • 7.4.6. Prostate Cancer
    • 7.4.7. Others

Chapter 8. Global Oncology Companion Diagnostic Market, by End Use

  • 8.1. Market Snapshot
  • 8.2. Global Oncology Companion Diagnostic Market by End Use, Performance - Potential Analysis
  • 8.3. Global Oncology Companion Diagnostic Market Estimates & Forecasts by End Use 2017-2027 (USD Billion)
  • 8.4. Oncology Companion Diagnostic Market, Sub Segment Analysis
    • 8.4.1. Hospital
    • 8.4.2. Pathology/Diagnostic Laboratory
    • 8.4.3. Academic Medical Center

Chapter 9. Global Oncology Companion Diagnostic Market, Regional Analysis

  • 9.1. Oncology Companion Diagnostic Market, Regional Market Snapshot
  • 9.2. North America Oncology Companion Diagnostic Market
      • 9.2.1.1. U.S. Oncology Companion Diagnostic Market
      • 9.2.1.2. Product & Service breakdown estimates & forecasts, 2017-2027
      • 9.2.1.3. Technology breakdown estimates & forecasts, 2017-2027
      • 9.2.1.4. Disease Type breakdown estimates & forecasts, 2017-2027
      • 9.2.1.5. End Use breakdown estimates & forecasts, 2017-2027
    • 9.2.2. Canada Oncology Companion Diagnostic Market
  • 9.3. Europe Oncology Companion Diagnostic Market Snapshot
    • 9.3.1. U.K. Oncology Companion Diagnostic Market
    • 9.3.2. Germany Oncology Companion Diagnostic Market
    • 9.3.3. France Oncology Companion Diagnostic Market
    • 9.3.4. Spain Oncology Companion Diagnostic Market
    • 9.3.5. Italy Oncology Companion Diagnostic Market
    • 9.3.6. Rest of Europe Oncology Companion Diagnostic Market
  • 9.4. Asia-Pacific Oncology Companion Diagnostic Market Snapshot
    • 9.4.1. China Oncology Companion Diagnostic Market
    • 9.4.2. India Oncology Companion Diagnostic Market
    • 9.4.3. Japan Oncology Companion Diagnostic Market
    • 9.4.4. Australia Oncology Companion Diagnostic Market
    • 9.4.5. South Korea Oncology Companion Diagnostic Market
    • 9.4.6. Rest of Asia Pacific Oncology Companion Diagnostic Market
  • 9.5. Latin America Oncology Companion Diagnostic Market Snapshot
    • 9.5.1. Brazil Oncology Companion Diagnostic Market
    • 9.5.2. Mexico Oncology Companion Diagnostic Market
  • 9.6. Rest of The World Oncology Companion Diagnostic Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Agilent Technologies, Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Illumina, Inc.
    • 10.2.3. QIAGEN N.V.
    • 10.2.4. Thermo Fisher Scientific, Inc.
    • 10.2.5. F. Hoffmann-La Roche Ltd.
    • 10.2.6. ARUP Laboratories
    • 10.2.7. Abbott
    • 10.2.8. Myriad Genetics, Inc.
    • 10.2.9. bioMerieux SA
    • 10.2.10. Invivoscribe, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Oncology Companion Diagnostic market, report scope
  • TABLE 2. Global Oncology Companion Diagnostic market estimates & forecasts by region 2017-2027 (USD Billion)
  • TABLE 3. Global Oncology Companion Diagnostic market estimates & forecasts by Product & Service 2017-2027 (USD Billion)
  • TABLE 4. Global Oncology Companion Diagnostic market estimates & forecasts by Technology 2017-2027 (USD Billion)
  • TABLE 5. Global Oncology Companion Diagnostic market estimates & forecasts by Disease Type 2017-2027 (USD Billion)
  • TABLE 6. Global Oncology Companion Diagnostic market estimates & forecasts by End Use 2017-2027 (USD Billion)
  • TABLE 7. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 18. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 19. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 20. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 21. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 22. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 23. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 24. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 25. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 26. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 27. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 28. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 29. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 30. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 31. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 32. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 33. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 34. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 35. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 36. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 37. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 38. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 39. Global Oncology Companion Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 40. Global Oncology Companion Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 41. U.S. Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 42. U.S. Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 43. U.S. Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 44. U.S. Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 45. U.S. Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 46. Canada Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 47. Canada Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 48. Canada Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 49. Canada Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 50. Canada Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 51. UK Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 52. UK Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 53. UK Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 54. UK Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 55. UK Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 56. Germany Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 57. Germany Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 58. Germany Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 59. Germany Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 60. Germany Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 61. France Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 62. France Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 63. France Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 64. France Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 65. France Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 66. Spain Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 67. Spain Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 68. Spain Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 69. Spain Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 70. Spain Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 71. Italy Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 72. Italy Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 73. Italy Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 74. Italy Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 75. Italy Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 76. ROE Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 77. ROE Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 78. ROE Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 79. ROE Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 80. ROE Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 81. China Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 82. China Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 83. China Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 84. China Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 85. China Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 86. India Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 87. India Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 88. India Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 89. India Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 90. India Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 91. Japan Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 92. Japan Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 93. Japan Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 94. Japan Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 95. Japan Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 96. Australia Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 97. Australia Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 98. Australia Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 99. Australia Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 100. Australia Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 101. South Korea Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 102. South Korea Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 103. South Korea Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 104. South Korea Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 105. South Korea Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 106. ROPAC Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 107. ROPAC Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 108. ROPAC Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 109. ROPAC Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 110. ROPAC Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 111. Brazil Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 112. Brazil Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 113. Brazil Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 114. Brazil Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 115. Brazil Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 116. Mexico Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 117. Mexico Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 118. Mexico Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 119. Mexico Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 120. Mexico Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 121. ROLA Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 122. ROLA Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 123. ROLA Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 124. ROLA Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 125. ROLA Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 126. ROW Oncology Companion Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 127. ROW Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 128. ROW Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 129. ROW Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 130. ROW Oncology Companion Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 131. List of secondary sources, used in the study of global Oncology Companion Diagnostic market
  • TABLE 132. List of primary sources, used in the study of global Oncology Companion Diagnostic market
  • TABLE 133. Years considered for the study
  • TABLE 134. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Oncology Companion Diagnostic market, research methodology
  • FIG 2. Global Oncology Companion Diagnostic market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Oncology Companion Diagnostic market, key trends 2019
  • FIG 5. Global Oncology Companion Diagnostic market, growth prospects 2020-2027
  • FIG 6. Global Oncology Companion Diagnostic market, porters 5 force model
  • FIG 7. Global Oncology Companion Diagnostic market, pest analysis
  • FIG 8. Global Oncology Companion Diagnostic market, value chain analysis
  • FIG 9. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 15. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 16. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 17. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 18. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 19. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 20. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 21. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 22. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 23. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 24. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 25. Global Oncology Companion Diagnostic market by segment, 2017 & 2027 (USD Billion)
  • FIG 26. Global Oncology Companion Diagnostic market, regional snapshot 2017 & 2027
  • FIG 27. North America Oncology Companion Diagnostic market 2017 & 2027 (USD Billion)
  • FIG 28. Europe Oncology Companion Diagnostic market 2017 & 2027 (USD Billion)
  • FIG 29. Asia Pacific Oncology Companion Diagnostic market 2017 & 2027 (USD Billion)
  • FIG 30. Latin America Oncology Companion Diagnostic market 2017 & 2027 (USD Billion)
  • FIG 31. Global Oncology Companion Diagnostic market, company market share analysis (2019)
Back to Top